Posey, Jr., et al., developed and characterized a new CAR based on the background of the Tn-MUC1-specific monoclonal antibody 5E5 that inhibits tumor growth in mouse models of leukemia and pancreatic cancer. This evidence concerns the gene MUC1 and pancreatic neoplasm.